The Latest Breaking News from Sanofi

In the UK a spring booster campaign has recently begun, offering an additional vaccine to people at highest risk from COVID. Between April and June 2023 people aged over 75, residents in care homes and children and adults aged five and up with weakened immune systems will be invited to…

The stock market major indexes posted weekly gains despite a volatile week. Surgical robotic company gaps up on analyst coverage news.

Eli Lilly & Co.’s announcement that it is slashing prices for its major insulin products could make life easier for some diabetes patients while easing pressure on Big Pharma.

Pfizer will buy Seagen for roughly $43 billion, and Sanofi will buy Provention for $2.9 billion. SGEN stock and PRVB stock soared.

Sanofi stock could shine in 2023 as the French pharma tees up a rival to Pfizer's experimental RSV vaccine for newborn babies.

London is still lagging behind parts of the country in terms of the vaccine uptake

Katie Eliot said she has experienced ‘amazing things’ in her life, despite bleak medical predictions in her youth

Big incumbent companies can't afford to fall behind in a new tech-and-science arms race.

Katie Eliot, 42, was diagnosed with tuberous sclerosis at 18 years old